These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38691100)

  • 1. Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance.
    Bugno J; Wang L; Yu X; Cao X; Wang J; Huang X; Yang K; Piffko A; Chen K; Luo SY; Naccasha E; Hou Y; Fu S; He C; Fu YX; Liang HL; Weichselbaum RR
    Clin Cancer Res; 2024 Oct; 30(19):4450-4463. PubMed ID: 38691100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.
    Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW
    Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.
    Anz D; Rapp M; Eiber S; Koelzer VH; Thaler R; Haubner S; Knott M; Nagel S; Golic M; Wiedemann GM; Bauernfeind F; Wurzenberger C; Hornung V; Scholz C; Mayr D; Rothenfusser S; Endres S; Bourquin C
    Cancer Res; 2015 Nov; 75(21):4483-93. PubMed ID: 26432403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.
    Muthuswamy R; Corman JM; Dahl K; Chatta GS; Kalinski P
    Prostate; 2016 Sep; 76(12):1095-105. PubMed ID: 27199259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
    Knitz MW; Bickett TE; Darragh LB; Oweida AJ; Bhatia S; Van Court B; Bhuvane S; Piper M; Gadwa J; Mueller AC; Nguyen D; Nangia V; Osborne DG; Bai X; Ferrara SE; Boss MK; Goodspeed A; Burchill MA; Tamburini BAJ; Chan ED; Pickering CR; Clambey ET; Karam SD
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells.
    Hao S; Han X; Wang D; Yang Y; Li Q; Li X; Qiu CH
    Immunology; 2016 Jun; 148(2):174-86. PubMed ID: 26868141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL22 Signaling in the Tumor Environment.
    Röhrle N; Knott MML; Anz D
    Adv Exp Med Biol; 2020; 1231():79-96. PubMed ID: 32060848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.
    Wiedemann GM; Röhrle N; Makeschin MC; Fesseler J; Endres S; Mayr D; Anz D
    Pathology; 2019 Oct; 51(6):586-592. PubMed ID: 31445808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.
    Oweida A; Hararah MK; Phan A; Binder D; Bhatia S; Lennon S; Bukkapatnam S; Van Court B; Uyanga N; Darragh L; Kim HM; Raben D; Tan AC; Heasley L; Clambey E; Nemenoff R; Karam SD
    Clin Cancer Res; 2018 Nov; 24(21):5368-5380. PubMed ID: 30042205
    [No Abstract]   [Full Text] [Related]  

  • 11. CCL1 is a major regulatory T cell attracting factor in human breast cancer.
    Kuehnemuth B; Piseddu I; Wiedemann GM; Lauseker M; Kuhn C; Hofmann S; Schmoeckel E; Endres S; Mayr D; Jeschke U; Anz D
    BMC Cancer; 2018 Dec; 18(1):1278. PubMed ID: 30572845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T-Cells Infiltration and Immunosuppression.
    Luo X; Huang W; Li S; Sun M; Hu D; Jiang J; Zhang Z; Wang Y; Wang Y; Zhang J; Wu Z; Ji X; Liu D; Chen X; Zhang B; Liang H; Li Y; Liu B; Wang S; Xu X; Nie Y; Wu K; Fan D; Xia L
    Adv Sci (Weinh); 2024 Sep; 11(36):e2310304. PubMed ID: 39072947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.
    Riezu-Boj JI; Larrea E; Aldabe R; Guembe L; Casares N; Galeano E; Echeverria I; Sarobe P; Herrero I; Sangro B; Prieto J; Lasarte JJ
    J Hepatol; 2011 Mar; 54(3):422-31. PubMed ID: 21129807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-Enhanced Expression of CCL22 in Nasopharyngeal Carcinoma is Associated With CCR4
    Li H; Chen X; Zeng W; Zhou W; Zhou Q; Wang Z; Jiang W; Xie B; Sun LQ
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):126-139. PubMed ID: 32428547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
    Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
    Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
    Muroyama Y; Nirschl TR; Kochel CM; Lopez-Bujanda Z; Theodros D; Mao W; Carrera-Haro MA; Ghasemzadeh A; Marciscano AE; Velarde E; Tam AJ; Thoburn CJ; Uddin M; Meeker AK; Anders RA; Pardoll DM; Drake CG
    Cancer Immunol Res; 2017 Nov; 5(11):992-1004. PubMed ID: 28970196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grooved Microneedle Patch Augments Adoptive T Cell Therapy Against Solid Tumors via Diverting Regulatory T Cells.
    Zhou R; Yu H; Sheng T; Wu Y; Chen Y; You J; Yang Y; Luo B; Zhao S; Zheng Y; Li H; Zhang Y; Guo Y; Gu Z; Yu J
    Adv Mater; 2024 Jul; 36(30):e2401667. PubMed ID: 38843541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors.
    Lin L; Kane N; Kobayashi N; Kono EA; Yamashiro JM; Nickols NG; Reiter RE
    Clin Cancer Res; 2021 Mar; 27(5):1505-1515. PubMed ID: 33219015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
    Uraki R; Imai M; Ito M; Shime H; Odanaka M; Okuda M; Kawaoka Y; Yamazaki S
    PLoS Pathog; 2021 Dec; 17(12):e1010085. PubMed ID: 34882757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.